Cite
MLA Citation
Nicolas M. Zahn et al.. “MIDD0301 – A first‐in‐class anti‐inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression.” Basic & clinical pharmacology & toxicology, vol. 125, no. 1, 2019, pp. 75–84. http://access.bl.uk/ark:/81055/vdc_100086210776.0x00000f